End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.2 CNY | +0.70% | -1.15% | -3.91% |
Apr. 30 | Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises | RE |
Apr. 26 | Cabio Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 535M 73.93M | Sales 2025 * | 680M 94M | Capitalization | 2.89B 400M |
---|---|---|---|---|---|
Net income 2024 * | 117M 16.17M | Net income 2025 * | 149M 20.6M | EV / Sales 2024 * | 5.41 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.26 x |
P/E ratio 2024 * |
24.7
x | P/E ratio 2025 * |
19.3
x | Employees | 444 |
Yield 2024 * |
1.57% | Yield 2025 * |
0.9% | Free-Float | 49.98% |
1 day | +0.70% | ||
1 week | -1.15% | ||
Current month | -12.47% | ||
1 month | +32.31% | ||
3 months | +42.74% | ||
6 months | -13.22% | ||
Current year | -3.91% |
Managers | Title | Age | Since |
---|---|---|---|
De Wei Yi
CEO | Chief Executive Officer | 59 | 04-09-21 |
Hua Biao Wang
DFI | Director of Finance/CFO | 59 | 04-09-21 |
Zhi Ming Wang
CTO | Chief Tech/Sci/R&D Officer | 55 | 04-09-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi fei Wang
BRD | Director/Board Member | 43 | 21-12-26 |
De Wei Yi
CEO | Chief Executive Officer | 59 | 04-09-21 |
Qi Liu
BRD | Director/Board Member | 47 | 21-12-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 17.2 | +0.70% | 9,405,697 |
24-05-17 | 17.08 | +1.91% | 7,277,188 |
24-05-16 | 16.76 | -1.41% | 7,696,562 |
24-05-15 | 17 | +0.35% | 6,501,455 |
24-05-14 | 16.94 | -2.64% | 9,236,328 |
End-of-day quote Shanghai S.E., May 19, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.91% | 398M | |
+17.16% | 8.43B | |
+3.57% | 7.49B | |
+6.50% | 6.23B | |
-4.70% | 3.75B | |
-6.75% | 3.75B | |
-3.55% | 1.33B | |
+14.40% | 1.02B | |
-9.25% | 933M | |
-17.08% | 801M |
- Stock Market
- Equities
- 688089 Stock